Vegfxta 400 mg Injection
  1. Home
  2. Pharma Products
  3. Fresenius Kabi India Pvt Ltd
  4. Vegfxta 400 mg Injection

Vegfxta 400 mg Injection

Vegfxta 400 mg Injection contains bevacizumab 400 mg and is an anticancer medicine used in the treatment of several advanced cancers. It is supplied as a 400 mg/16 mL solution in a single-use vial for intravenous infusion under medical supervision. Bevacizumab works by blocking vascular endothelial growth factor (VEGF), which helps reduce the formation of blood vessels that supply tumors.

BUY NOW

Category

Vegfxta is a monoclonal antibody that may be used with other anticancer medicines for conditions including colorectal cancer, non-small cell lung cancer, kidney cancer, cervical cancer, ovarian cancer, and certain brain tumors. By inhibiting VEGF, it can restrict the blood supply that tumors require for continued growth. The medicine is administered through intravenous infusion, with the dose and treatment schedule selected according to the cancer type and prescribed treatment regimen. Patients require appropriate monitoring because bevacizumab can be associated with hypertension, bleeding, proteinuria, impaired wound healing, and infusion-related reactions.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 400 mg
Presentation 400 mg/16 mL
Concentration 25 mg/mL
Dosage Form Solution for infusion
Route of Administration Intravenous infusion

Product Also Known As

Vegfxta 400mg Injection, Vegfxta 400mg/16ml Injection, Bevacizumab 400mg Injection, Bevacizumab 400mg/16ml Infusion, Bevacizumab Injection 400mg, Bevacizumab 25mg/ml Infusion